A prioritization analysis of disease association by data-mining of functional annotation of human genes
Complex diseases result from contributions of multiple genes that act in concert through pathways. Here we present a method to prioritize novel candidates of disease-susceptibility genes depending on the biological similarities to the known disease-related genes. The extent of disease-susceptibility...
Gespeichert in:
Veröffentlicht in: | Genomics (San Diego, Calif.) Calif.), 2012, Vol.99 (1), p.1-9 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Complex diseases result from contributions of multiple genes that act in concert through pathways. Here we present a method to prioritize novel candidates of disease-susceptibility genes depending on the biological similarities to the known disease-related genes. The extent of disease-susceptibility of a gene is prioritized by analyzing seven features of human genes captured in H-InvDB. Taking rheumatoid arthritis (RA) and prostate cancer (PC) as two examples, we evaluated the efficiency of our method. Highly scored genes obtained included
TNFSF12 and
OSM as candidate disease genes for RA and PC, respectively. Subsequent characterization of these genes based upon an extensive literature survey reinforced the validity of these highly scored genes as possible disease-susceptibility genes. Our approach, Prioritization ANalysis of Disease Association (PANDA), is an efficient and cost-effective method to narrow down a large set of genes into smaller subsets that are most likely to be involved in the disease pathogenesis.
► We develop a method to prioritize novel candidates of disease-susceptibility genes. ► Our method uses functional similarities to known disease-related genes. ► TNFSF12 is predicted as a candidate gene for rheumatoid arthritis. ► OSM is predicted as a candidate gene for prostate cancer. ► Our method called PANDA appears to be effective to prioritize disease-related genes. |
---|---|
ISSN: | 0888-7543 1089-8646 |
DOI: | 10.1016/j.ygeno.2011.10.002 |